A Retrospective study of intravitreal Bevacizumab treatment in patients with macular edema secondary to branch retinal vein occlusion and central retinal vein occlusion (BERVOLT study)
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- Acronyms BERVOLT
- 06 Apr 2017 New trial record